ARCHIVES

NCI Lung Cancer Mutation Consortium: Screening For Mutations Can Focus Therapy

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Deputy Commissioner Friedman Named Senior VP, Clinical Affairs, At G.D. Searle

June 16, 1999

BSA Approves Trial of Carbon Ion Therapy, Extends EDRN And Provocative Questions

July 4, 2014

In Brief: Susumu Tonegawa To Receive Bristol-Myers Award; Mark Green Named Director Of UCSD Cancer Center

March 7, 1986

NCI Largely Unaffected By NIH Translational Research Center

February 11, 2011

Group Chairs Seek Role Running NCTN

September 12, 2014

Bush Appoints Niederhuber Chairman of NCAB

August 2, 2002